The George Institute for Global Health
Research facility
Location:
Newtown,
Australia (AU)
ISNI: 0000000119646010
ROR: https://ror.org/023331s46
Show on Map:
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials (2025)
Badve SV, Bilal A, Lee MM, Sattar N, Gerstein HC, Ruff CT, McMurray JJ, et al.
Journal article
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts. (2023)
Canney M, Induruwage D, Tang M, Alencar de Pinho N, Er L, Zhao Y, Djurdjev O, et al.
Journal article
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease (2021)
McMurray JJ, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, et al.
Journal article
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks—A Narrative Review (2020)
Clase CM, Fu EL, Ashur A, Beale RC, Clase IA, Dolovich MB, Jardine MJ, et al.
Journal article, Review article
International consensus definitions of clinical trial outcomes for kidney failure: 2020 (2020)
Levin A, Agarwal R, Herrington WG, Heerspink HL, Mann J, Shahinfar S, Tuttle KR, et al.
Journal article